TORRENT PHARMACEUTICALS
|
The Current P/E Ratio of TORRENT PHARMACEUTICALS is 77.61.
| Share Price | ₹4,903.4 | Jul 10,2026 |
| Market Cap | ₹165,929.4 Cr | |
| Earnings-TTM | ₹2,138.0 Cr | TTM-Consolidated Results |
| Price/Earnings | 77.61x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of TORRENT PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹165,929.4 Cr] as on Jul 10,2026
(/) Earnings [ ₹2,138.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 77.61x ]
Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay 77.61 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of TORRENT PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of TORRENT PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of TORRENT PHARMACEUTICALS
PE Ratio Performance Analysis for TORRENT PHARMACEUTICALS
- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 49.74x.
- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 53.15x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2026 at 66.03x.
- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2022 of 30.45x.
How does TORRENT PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| TORRENT PHARMACEUTICALS | 2,138.00 | 77.61 | 165,929.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 40.15 | 464,331.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 70.66 | 181,466.0 |
| CIPLA LTD | 3,869.79 | 30.03 | 116,229.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 25.09 | 103,959.0 |
| MANKIND PHARMA LTD | 1,926.41 | 54.13 | 104,275.0 |
| LUPIN LTD | 5,355.47 | 21.31 | 114,128.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.83 | 114,763.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 25.71 | 90,026.5 |
| LAURUS LABS LTD | 889.85 | 93.39 | 83,103.9 |
| BIOCON LTD | 368.80 | 184.91 | 68,194.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs TORRENT PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 21.31x |
| Max industry PE | 184.91x |
| Median industry PE | 40.15x |
| Average industry PE | 58.71x |
You may also like the below Video Courses